Novavax Files for Provisional Approval of its COVID-19 Vaccine in Australia-- Application marks the first protein-based COVID-19 vaccine submitted to regulatory authorities for provisional approval in Australia-- In addition to today's submission to the Therapeutic Goods Administration, the company recently filed for authorization with MHRA, with additional filings in process-- All modules required for Australian regulatory evaluation, including Quality/ CMC data, are now complete
Finally here we have Novavax
Novavax Files for Provisional Approval of its COVID-19 Vaccine...
Add IDT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $49.43M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 294967 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 459739 | 7 |
View Market Depth
| Last trade - 11.08am 03/10/2024 (20 minute delay) ? |
| IDT (ASX) Chart |
Day chart unavailable